CBD-Intel

Business briefing

US Postal Service offers guidance on mail delivery of CBD products

Written by Daniel Mollenkamp || 4th April 2019 || Business briefing |

North America
United States
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Business briefing
Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the...

Mainstream US drugstore chains announce plans to sell CBD

Written by Daniel Mollenkamp || 29th March 2019 || Business briefing |

Alabama
California
Colorado
Illinois
Indiana
Kentucky
Maryland
New Mexico
North America
Oregon
South Carolina
Tennessee
United States
Vermont
Companies
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Business briefing
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has...

Big dollars are undeterred by red tape tangle and inconsistent enforcement

Written by CBD-Intel || 11th March 2019 || Business briefing |

Canada
North America
United States
Companies
Marketing and Retailing
Public Health and Medicine
Business briefing
North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses ...

CBD to treat concussion disorders? Retired NHL players join study

Written by CBD-Intel || 8th March 2019 || Business briefing |

Canada
North America
United States
Companies
Public Health and Medicine
Technology and Innovation
Business briefing
A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders ...

GW Pharmaceuticals reports loss despite success of CBD-based drug

Written by Freddie Dawson || 1st March 2019 || Business briefing |

England
Europe
North America
United Kingdom
United States
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Business briefing
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan ...

Deal signals plans for ‘sustainable’ bio-synthesised CBD

Written by CBD-Intel || 26th February 2019 || Business briefing |

North America
United States
Companies
Business briefing
The commercialisation of bio-synthesised cannabidiol could be on the horizon following the announcement by Amyris that it will be forming a new partnership to focus on “cannabinoid development”. The California-based company is best known for creating synthetic sweeteners...

Global CBD rules will get tougher, then normalise, expert predicts

Written by Daniel Mollenkamp || 20th February 2019 || Business briefing |

Europe
France
North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Business briefing
Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert ...

‘More women than men’ have tried CBD in UK

Written by Freddie Dawson || 19th February 2019 || Business briefing |

England
Europe
United Kingdom
Regulation and Legislation
Business briefing
More women than men have tried CBD products, according to a new report from CBD-Intel. Among other findings in the report is that health-conscious men are more likely than others to try CBD ...

Science review sees promise and problems in medical use of CBD

Written by Barnaby Page || 19th February 2019 || Business briefing |

Connecticut
North America
United States
Public Health and Medicine
Business briefing
CBD shows promise for treating some medical conditions but the potential for interactions with other drugs is a cause for concern, as is poor quality control, according to a recent review of science in the field ...

Cannabis companies team up with pharma firm to supply Europe

Written by CBD-Intel || 14th February 2019 || Business briefing |

Canada
Europe
Greece
North America
Poland
United States
Companies
Business briefing
Two of the largest legal cannabis companies, Wayland and International Cannabis Corp, are teaming up with a multinational pharmaceutical organisation in a bid to create significant amounts of CBD for the European market ...

Israel can grow its cannabis and CBD sector with government blessing

Written by CBD-Intel || 7th February 2019 || Business briefing |

Asia
Israel
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Business briefing
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry ...

Argentina – land of opportunity beset by confusion and doubt

Written by ECigIntelligence || 29th January 2019 || Business briefing |

Argentina
South America
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Business briefing
A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities ...

CBD to enter the big-time with coffee ads at the Super Bowl

Written by Daniel Mollenkamp || 28th January 2019 || Business briefing |

North America
United States
Companies
Marketing and Retailing
Business briefing
A series of advertisements for CBD products will be seen at Sunday’s Super Bowl LIII between the New England Patriots and the LA Rams, powerfully demonstrating their arrival in the US mainstream ...

Kosher product approval achieved by two CBD companies

Written by CBD-Intel || 25th January 2019 || Business briefing |

Asia
Europe
Israel
Companies
Marketing and Retailing
Business briefing
Two CBD products have received kosher status from the largest agency in Europe dealing with rabbinically-approved foodstuffs. London-based Advance Biotech received kosher certification from KLBD Kosher Certification in September 2018, followed by Provocan, a CBD brand made by Jerusalem-based...

LloydsPharmacy may be path to stronger CBD for UK supermarkets

Written by Freddie Dawson || 21st January 2019 || Business briefing |

England
EU
Europe
Northern Ireland
Scotland
United Kingdom
Wales
Companies
Marketing and Retailing
Public Health and Medicine
Business briefing
Though Lloyds is a lesser name than Boots among UK pharmacy chains, its partnership with Sainsbury’s means it could be poised to dramatically expand the range of the supermarket’s CBD product offerings. LloydsPharmacy started stocking a range of CBD...

Online seller accuses others of using CBD as ‘a marketing tool’

Written by CBD-Intel || 10th January 2019 || Business briefing |

Europe
United Kingdom
Companies
Marketing and Retailing
Regulation and Legislation
Business briefing
The co-founder of an online CBD shop has accused rivals of deceptive marketing. Johan Obel of TheDrug.Store also called for more clarity – and tighter controls – over what is and is not legal in the UK...

The shape of things to come: what 2019 will bring for CBD

Written by Freddie Dawson || 31st December 2018 || Business briefing |

Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Business briefing
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead...

CBD beverage companies step into the future with nanoemulsions

Written by CBD-Intel || 28th December 2018 || Business briefing |

Europe
United Kingdom
World
Companies
Marketing and Retailing
Technology and Innovation
Business briefing
Companies which make beverages containing CBD are resorting to new technologies to get around a thorny problem. CBD is not water soluble, meaning a fatty emulsion needs to be created in order to get the substance to mix with...

Sign up to our newsletter

By signing up you agree to our Terms and Conditions